Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 269-052-1 | CAS number: 68186-90-3 This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77310.
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
in vitro Gene mutagenicity in bacteria Ames test (S. typhimurium strains TA 98, TA 100, TA 1535, TA 1537, TA 1538 and E. coli WP2 uvrA), with or without metabolic activation: negative (OECD 471, BASF 1985).
Gene mutagenicity in mammalian cells Mouse lymphoma assay, L5178Y cells, with or without metabolic activation: negative (OECD 476; BASF 1996)
Cytogenicity in mammalian cells Micronucleus formation in vitro, CHL V79, with or without metabolic activation: negative (OECD 487; BASF 2001).
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Gene mutagenicity in bacteria
A reverse gene mutation assay in bacteria, performed according to
OECD guideline 471 is available (BASF 1995). The tester strains used
in this assay were Salmonella typhimurium strains TA98, TA100, TA1535,
TA1537, TA 1538 and the Escherichia coli tester strain WP2 uvrA. The
strains were exposed to concentrations of 100, 250, 500, 1000, 2500
and 5000 µg/plate in the presence and absence of S9 mix along with
concurrent vehicle (DMSO) and positive controls. Under the conditions
of this test, the test substance did not cause a positive increase in
the number of revertants per plate of any of the tester strains either
in the presence or absence of S9 mix.
Gene mutagenicity in mammalian cells
The target substance was tested for genetic toxicity in vitro
in a cell gene mutation test with mouse lymphoma cells according to
OECD guideline 476 (CHV 1996). In the mutation assay test substance
concentrations (suspension in DMSO) of 3.13, 6.25, 12.5, 25.0, 50.0
and 100 µg/mL were tested in the presence and absence of rat liver S9
metabolic activation. Higher concentrations were not tested because of
the insoluble nature of the test substance. All dosing solutions were
washed to remove the visible precipitate before application. Two
trials of the non-activation and the S9 metabolic activation mutation
assay were performed but the first trial was unacceptable because of
problems in the cell cultures. In Trial 2, six treatments from 3.13 to
100 µg/mL were initiated and all doses were cloned for mutation
analysis. No cytotoxicity was observed under either activation
conditions.
None of the six analyzed treatments with or without metabolic activation included a mutation frequency that exceeded the minimum criterion for a positive response. Thus, the test substance was negative with or without metabolic activation in the TK locus in L5178Y lymphoma cells under the conditions of this study.
Cytogenicity in mammalian cells
A GLP compliant in vitro micronucleus test
was performed according to OECD guideline 487 (BASF 2001). CHL V79
cells were exposed to the following test substance doses:
Mixed Population Method
24 h exposure, 24 h harvest time, without S9-mix
0, 1.25, 2.5, 5, 10, 15 µg/mL
4 h exposure, 24 h harvest time, with S9-mix
0, 1.25, 2.5, 5, 10, 15 µg/mL
Mitotic Shake Off Method (24 h mitotic shake off)
24 h exposure, 27 h preparation time, without S9-mix
0, 0.78, 1.56, 3.125, 6.25, 12.5 µg/mL
4h exposure, 27 h preparation time, with S9-mix
0, 1.56, 3.125, 6.25, 12.5, 25 µg/mL
Strong test substance precipitation in the vehicle was observed at all
test doses. In culture the test substance was obviously soluble up to
6.25 µg/mL.
On the basis of the results of the present
study, the test substance did not cause any increase in the number of
cells containing micronuclei either without S-9 mix or after adding a
metabolizing system. These findings were confirmed in two modified
versions of the in vitro micronucleus assay carried out independently
of each other.
Thus, under the experimental conditions of this assay, the test
substance is considered not to be a chromosome-damaging (clastogenic)
agent nor did it induce numerical chromosomal aberrations (aneugenic
activity) under in vitro conditions in V79 cells .
Justification for classification or non-classification
Classification, Labelling, and Packaging Regulation (EC) No 1272/2008
The available experimental test data are reliable and suitable for classification purposes under Regulation 1272/2008. Based on the available in vitro data, the test item is not classified according to Regulation (EC) No 1272/2008 (CLP), as amended for the ninth time in Regulation (EC) No 2016/1179.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
